Latest News about jnj
Recent news which mentions jnj
ADHD Drug Developer Cingulate Plans NASDAQ Debut
September 10, 2021
From Benzinga
You ought to favor large-cap stocks through the end of the year
September 10, 2021
From MarketWatch
Endo Shares Move Higher On Settlement Of New York State Opioid Cases
September 10, 2021
From Benzinga
Could This Be Pfizer's Next Blockbuster Vaccine?
September 10, 2021
From Motley Fool
Could This Game-Changing FDA Approval Mean Profit for Johnson & Johnson Shareholders?
September 10, 2021
Tickers
JNJ
From Motley Fool
Here's the Next Blockbuster Vaccine Opportunity for Pfizer
September 10, 2021
From Motley Fool
Coca-Cola And Merck Lead The Dow Jones Lower
September 09, 2021
From Benzinga
Why Shares of Johnson & Johnson Are Down 2% Today
September 09, 2021
From Motley Fool
This Controversial Move Could Save Johnson & Johnson Billions
September 09, 2021
Tickers
JNJ
From Motley Fool
EMA To Add New Side Effects To Janssen, AstraZeneca COVID-19 Shots
September 08, 2021
From Benzinga
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
Johnson & Johnson's Prostate Cancer Drug Erleada Wins NICE Approval
September 08, 2021
Tickers
JNJ
From Benzinga
Downgrades On Economy And Pandemic Pharmaceuticals
September 08, 2021
From Benzinga
From Benzinga
Vaxart Stock Is One Vaccine Also-Ran Worth Another Look
September 08, 2021
From InvestorPlace
Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
September 07, 2021
From Benzinga
This Cancer Screening Company Has A Better 5-Year Return Than Pfizer, Johnson & Johnson And Gilead
September 06, 2021
From Benzinga
If You're Retired, Consider Buying These 5 Stocks
September 06, 2021
From Motley Fool
From MarketWatch
What Are the Prospects for Moderna?
September 05, 2021
From Motley Fool
This Is the COVID Vaccine Stock You Want to Own
September 04, 2021
From Motley Fool
Investors care more about fair wages for workers than environmental issues, ESG survey shows
September 04, 2021
From MarketWatch
Trump weighs in on vaccine booster shots: ‘I’ll look at stuff later on. I’m not against it, but it’s probably not for me.’
September 03, 2021
From MarketWatch
COVID-19 Vaccine Booster Shots Will Have To Wait, FDA Tells White House: WSJ
September 03, 2021
From Benzinga
Fauci says mu variant of coronavirus not an ‘immediate threat’ to U.S. as delta remains dominant
September 03, 2021
From MarketWatch
From Benzinga
White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report
September 03, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.